The Weekly Roundup: October 24-28

POLL: Did You Follow Fall Clinical Coverage From Dermatology Times®?

Click here to answer this week's poll.

Continuing Medical Education: 3 Things You Should Know About Managing Alopecia Areata

Alopecia areata can have devastating effects on patients, but a greater understanding of its pathophysiology has led to the development of new treatment options.

US Dermatologists Have Growth Opportunity in Wound Care

Dermatologists may not treat as many advanced wounds as would be expected.

Unilever Issues Voluntary Recall for Popular Dry Shampoo Brands

Dry shampoo products were found to contain elevated levels of a cancer-causing chemical.

Systemic Treatment of Atopic Dermatitis Relieves Skin Symptoms and Reduces Depression

A real-world, cohort study finds popular skin rash drugs also boost moods.

5th Personal Care Product Category Recalled for Heightened Levels of Benzene

Christopher Bunick, MD, PhD, discusses the 5th personal care product category recall, dry shampoos, due to heightened levels of benzene.

The Mainstream Patient: October 25

This week's edition of the Mainstream Patient features stories about how to treat melasma, an honest reflection on skin picking, the beauty in breast cancer scars, and more.

Pointers With Portela: Dermarolling

In this week’s Pointers with Dr Portela, the 208SkinDoc reviews the social media phenomenon of "dermarolling."

New Study Ties Sleep Loss to Overactive Immune System

Small study finds that sleep deprivation increases white blood cells. The finding is a piece of a puzzle that may link poor sleep to inflammation and a number of diseases.

Phase 3 Results of Epidermolysis Bullosa Trial Published in British Journal of Dermatology

Amryt Pharma’s phase 3 trial, EASE, is the largest phase 3 trial in epidermolysis bullosa.

New Aveeno Report Reveals 71% of Adults Have Sensitive Skin

State of Skin Sensitivity Report raises awareness of the causes of skin sensitivity and its effect on the mind.

3 Approaches to Creating a Connected Care Future

By integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.

Study Evaluates Safety and Efficacy of Oral Zinc and Low-Dose Isotretinoin for Acne Vulgaris

Numerous adverse effects are associated with standard-dose isotretinoin.

Recap from Fall Clinical

Catch up on coverage from the 2022 Fall Clinical Dermatology Conference.

How Bad is Inflation? Physicians, Financial Managers Report the Latest

MGMA survey quantifies rising costs, revenues, patient encounters, and more.

The Weekly Roundup: October 24-28

ICYMI, this week we had stories about product recalls due to benzene, advanced wound care in the US, a Fall Clinical recap, and more.